Comparing Gene Silencing and Physiochemical Properties in siRNA Bound Cationic Star-Polymer Complexes

Megan Dearnley1, Nicholas P Reynolds2, Peter Cass3

  • 1CSIRO-Health and Biosecurity Business Unit, Australian Animal Health Laboratory , 5 Portarlington Road, Geelong, Vic 3220, Australia.

Biomacromolecules
|October 7, 2016
PubMed

Insights

Cationic acrylic polymers effectively deliver small interfering RNA (siRNA) for gene silencing. This study characterizes polymer-siRNA complexes, identifying key physical properties for successful therapeutic delivery.

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Molecular Biology

Background:

  • Clinical translation of small interfering RNA (siRNA) therapies is hindered by delivery challenges.
  • Naked siRNA faces difficulties in reaching target cells effectively.

Purpose of the Study:

  • To investigate siRNA delivery using cationic acrylic polymers synthesized via Reversible Addition-Fragmentation chain Transfer (RAFT) polymerization.
  • To analyze the impact of protein corona on siRNA-polymer complex characteristics and biological activity.
  • To establish structure-function relationships for optimized nanotherapeutic design.

Main Methods:

  • Synthesis of siRNA-star polymer complexes using RAFT polymerization.
  • Characterization using nanoscale mechanical-atomic force microscopy, dynamic light scattering, and nanoparticle tracking analysis.
  • In vitro assessment of cell uptake and gene silencing efficacy.

Main Results:

  • Comprehensive physiochemical analysis of siRNA-polymer complexes, with and without protein corona.
  • Identification of desirable physical features (morphology, stiffness, surface charge) promoting gene silencing.
  • Correlation between physical properties and biological performance of the nanodelivery system.

Conclusions:

  • Cationic acrylic polymers show promise for effective siRNA delivery.
  • Understanding physiochemical properties is crucial for designing efficient polymer-mediated siRNA nanotherapeutics.
  • This multidisciplinary approach facilitates rational design for novel therapeutic strategies.